Alpine Woods Capital Investors, LLC Amgen Inc Transaction History

Alpine Woods Capital Investors, LLC

$626 Million
Q3 2024

A detailed history of Alpine Woods Capital Investors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Alpine Woods Capital Investors, LLC holds 33,032 shares of AMGN stock, worth $9.25 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares

33,032

Previous 36,945 10.59%

Holding current value

$9.25 Million

Previous $11.5 Million 7.8%

% of portfolio

1.7%

Previous 1.6%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $1.21 Million - $1.32 Million	-3,913 Reduced 10.59%	33,032 $10.6 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $2.95 Million - $3.58 Million	11,209 Added 43.55%	36,945 $11.5 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $1.26 Million - $1.52 Million	-4,675 Reduced 15.37%	25,736 $7.32 Million
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $128,872 - $145,383	504 Added 1.69%	30,411 $8.76 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $357,055 - $443,294	-1,633 Reduced 5.18%	29,907 $8.04 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $116,777 - $138,086	-545 Reduced 1.7%	31,540 $7 Million
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $640,792 - $781,017	-2,838 Reduced 8.13%	32,085 $7.76 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $492,872 - $626,253	2,152 Added 6.57%	34,923 $9.17 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $60,828 - $68,603	-271 Reduced 0.82%	32,771 $7.39 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $20,302 - $22,593	-88 Reduced 0.27%	33,042 $8.04 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $303,031 - $335,231	-1,382 Reduced 4.0%	33,130 $8.01 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $402,334 - $460,434	2,023 Added 6.23%	34,512 $7.76 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $514,542 - $602,848	-2,424 Reduced 6.94%	32,489 $6.91 Million
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $75,446 - $83,702	323 Added 0.93%	34,913 $8.51 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $487,536 - $568,144	2,197 Added 6.78%	34,590 $8.61 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $388,402 - $462,517	1,795 Added 5.87%	32,393 $7.45 Million
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $2.4 Million - $2.67 Million	10,248 Added 50.36%	30,598 $7.78 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $674,729 - $827,986	3,411 Added 20.14%	20,350 $4.8 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $478,380 - $634,462	2,625 Added 18.34%	16,939 $3.43 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $20,056 - $25,779	-106 Reduced 0.74%	14,314 $3.45 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $20,022 - $23,991	-115 Reduced 0.79%	14,420 $2.79 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $38,007 - $44,553	228 Added 1.59%	14,535 $2.68 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $13,926 - $15,698	77 Added 0.54%	14,307 $2.72 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $101,688 - $118,702	-570 Reduced 3.85%	14,230 $2.77 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $18,529 - $20,889	-100 Reduced 0.67%	14,800 $3.07 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $1.14 Million - $1.28 Million	-6,850 Reduced 31.49%	14,900 $2.75 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $202,548 - $226,308	-1,200 Reduced 5.23%	21,750 $3.78 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $3.84 Million - $4.38 Million	22,950	22,950 $4.28 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.

Account

Alpine Woods Capital Investors, LLC Amgen Inc Transaction History